For those looking to find strong Basic Materials stocks, ... ATI has gained about 52.8% so far this year. At the same time, Basic Materials stocks have gained an average of 9%.

This is an open label, single arm Phase 2 study, enrolling patients with melanoma either currently or previously having received a PD-1 based therapy and, if BRAF V600 mutated, a BRAF-based therapy.